The firm is hiring new scientific and managerial staff as it targets distinct markets in Africa for its nucleic acid amplification-based resistance test.
Prequalification now enables procurement in numerous countries within sub-Saharan Africa that have regulations requiring this type of oversight.
The prototype showed biases at low virus concentrations and the researchers raised concerns over use of whole blood versus plasma HIV RNA as a biomarker.
The researchers combined epitope tagging and affinity-capture mass spec to investigate interactors of two HIV proteins as they exist in functional viruses.
Researchers in San Diego collaborated with the American Red Cross to enable molecular testing, reducing incidence in the zip codes where screening was offered.
Researchers report this week that HIV-1 can become resistant to CRISPR/Cas9 editing.
Two recent studies confirm that CRISPR/Cas9 can edit and inhibit latent HIV provirus, but one of them hints that the virus can develop resistance to excision.
Researchers used viral repertoire sequencing to characterize an early-stage HIV-neutralizing antibody, an important step toward developing a vaccine.
The firm's dual assay for host antigen to HIV as well as viral RNA was described in a proof-of-principle study earlier this year.
The company'sExatype software is a web-based solution for locating HIV drug resistance mutations using raw NGS data and other functional information.
A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.
LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.
The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.
In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.